Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

AmplifyBio Establishes New Albany, Ohio, Facility

05/25/2022
AmplifyBio, a biotechnology contract research organization that aims to advance the quality and innovation of human health and advanced therapies, will establish a new 350,000-square-foot facility in New Albany, Ohio. The $150 million project is expected to create 132 jobs in the Columbus region.

The company is expanding to meet surging market demand for advanced therapies, including cell and gene therapy products. AmplifyBio also plans to create 99 jobs at its 30-acre campus at 1425 Plain-City Georgesville Road in West Jefferson.

“We are excited to expand our presence in the Columbus Region, and specifically New Albany. We believe that our innovation platform is a perfect fit for the collaborative environment that I first noticed when I came to Ohio,” commented AmplifyBio CEO and President J. Kelly Ganjei. “Our partners, collaborators and clients view working in the Region as a phenomenal opportunity, and we are convinced that our business model will continue to drive more innovative developers into the area.”

AmplifyBio is leveraging decades of experience in supporting advanced therapies using a variety of modern clinical and commercial drug development solutions. The company focuses on safety, efficacy and toxicology testing for best-in-class and advanced therapy drug candidates to accelerate the development of scalable products. In 2021, AmplifyBio raised $200 million in early-stage venture capital investments, the second largest VC investment in the Columbus Region last year.

“AmplifyBio’s growth is further evidence of the rapidly growing biotech sector throughout the state and Region,” said JobsOhio CEO J.P. Nauseef. “The unique opportunities in research and development that AmplifyBio’s expansion is bringing to the Region, with a mission to advance healthcare for all, is a big win for our workforce and our knowledge economy.”

Exclusive Research